Always Remember - Buy The Dip

Sentiment Analysis For OHRP

The news is currently generally neutral for OHRP.

Based on TextBlob analysis of Yahoo! Finance news summaries for OHRP on 2015-09-05.

Yahoo! Finance News for OHRP

Ohr Pharmaceutical Jumps on Positive Eye Drug Study Data - Analyst Blog
Ohr Pharmaceutical, Inc. 's OHRP shares soared almost 63% immediately after the company reported positive final data from a phase II study on its lead pipeline candidate, OHR 102 (0.2% squalamine lactate ophthalmic solution), which is being evaluated for

Ohr Phase 2 Trial Shows Positive Results For OHR-102 In Retinal Vein Occlusion
Ohr Phase 2 Trial Shows Positive Results For OHR-102 In Retinal Vein Occlusion

OHR Pharmaceutical (OHRP) Enters Oversold Territory - Tale of the Tape
OHR Pharmaceutical Inc ( OHRP ) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope

Ohr Pharmaceutical Crashes on Disappointing Eye Drug Data - Analyst Blog
Ohr Pharmaceutical, Inc. 's OHRP shares plunged 68.6% immediately after the company reported disappointing top line results from an exploratory phase II study (IMPACT) evaluating OHR 102 (0.2% squalamine lactate ophthalmic solution) combination therapy for the treatment of patients

Ohr Pharmaceutical (OHRP) Jumps: Stock Moves 27.2% Up - Tale of the Tape
Ohr Pharmaceutical, Inc. ( OHRP ) was a big mover last session, as the company saw its shares rise over 27% on the day. Shares rallied on the company's presentation of additional positive anatomic data from the OHR 102

Ohr Pharmaceutical (OHRP) in Focus: Stock Falls 8.4% - Tale of the Tape
Ohr Pharmaceutical, Inc. ( OHRP ) saw a big move last session, as the company's shares fell by over 8% on the day. The move came on pretty good volume too with far more shares changing hands than in

Ohr Pharmaceutical's OHR-102 to Enter Phase III in 1H15 - Analyst Blog
Investors in the pharma biotech sector eagerly wait for pipeline updates as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give

Can the Rally in OHR Pharmaceutical (OHRP) Shares Continue? - Tale of the Tape
OHR Pharmaceutical Inc ( OHRP ) has been on the move lately as the stock has risen by 15.6% in the past four weeks, and it is currently trading well above its 20 Day SMA. This is a pretty

Anacor Pharmaceuticals, Inc. (ANAC) in Focus: Stock Surges 6.76% - Tale of the Tape
Anacor Pharmaceuticals, Inc. ( ANAC ) was a big mover last session, as the company saw its shares surge nearly 7% on the day. This rally higher can be attributable to solid volume with far more shares changing hands

Genocea Biosciences, Inc. (GNCA) in Focus: Stock Rises 7.52% - Tale of the Tape
Genocea Biosciences, Inc. ( GNCA ) was a big mover last session, as the company saw its shares rise over 7% on the day. This rally higher can be attributable to solid volume too with far more shares changing

Strength Seen in La Jolla Pharmaceutical Co. (LJPC): Stock Shoots 19% - Tale of the Tape
La Jolla Pharmaceutical Co. ( LJPC ) was a big mover last session, as the company saw its shares surge 19% on the day. This massive rally can be attributable to solid volume with far more shares changing hands

Aerie Pharmaceuticals, Inc. (AERI) in Focus: Stock up 8.37% - Tale of the Tape
Aerie Pharmaceuticals, Inc. ( AERI ) was a big mover last session, as the company saw its shares rise over 8% on the day. This rally higher can be attributable to solid volume with far more shares changing hands

Ohr Pharmaceutical (OHRP) Soars: Stock Adds 16.9% in Session - Tale of the Tape
Ohr Pharmaceutical, Inc. ( OHRP ) was a big mover last session, as the company saw its shares rise by almost 17% on the day. The move came on solid volume too with far more shares changing hands than

Recro Pharma (REPH) in Focus: Stock Gains 6.5% - Tale of the Tape
Recro Pharma, Inc. ( REPH ) was a big mover last session with its shares rising over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.

Onconova Therapeutics (ONTX) in Focus: Stock Up 14.0% - Tale of the Tape
Onconova Therapeutics, Inc. ( ONTX ) was a big mover last session with its shares rising just over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal

OHR Pharmaceutical (OHRP) is now in Oversold Territory - Tale of the Tape
OHR Pharmaceutical Inc 's ( OHRP ) share price has entered into oversold territory with an RSI value of 27.7. The Zacks Consensus Estimate for OHR Pharmaceutical for the full year period has improved 27 cents over